Comparison Overview
Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc.
Berkeley, US
Last Update: 19/02/2026
Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing ...

Agilent Technologies
5301 Stevens Creek Boulevard, Santa Clara, 95051, US
Last Update: 01/04/2026
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them...
Compliance Ranges Comparison

Carmot Therapeutics, Inc.







Agilent Technologies






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Carmot Therapeutics, Inc. in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Agilent Technologies in 2026.
Incident History - Carmot Therapeutics, Inc. (X = Date, Y = Severity)
Carmot Therapeutics, Inc. cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Agilent Technologies (X = Date, Y = Severity)
Agilent Technologies cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Carmot Therapeutics, Inc.

Agilent Technologies
FAQ
Latest Global CVEs
Fides is an open-source privacy engineering platform. From version 2.33.0 to before version 2.84.5, there is a DOM-based XSS vulnerability in fides.js via the fides_description override. This issue has been patched in version 2.84.5.
WACRM prior to commit 73041bf contain an authorization bypass vulnerability in the automation engine that allows authenticated attackers to access and modify contacts belonging to other tenants by supplying an arbitrary caller-controlled contact_id in the POST request body without tenant ownership verification. Attackers can exploit the service-role client that bypasses row-level security to modify victim contact fields including name, email, and company across tenant boundaries using only a known contact UUID.
Namespace attributes are not encoded correctly during HTML serialization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.
When ALLOW_INSECURE_RAW_TEXT is enabled, whitespace-variant closing tags (e.g., </style\t>) are not recognized by the sanitizer but accepted by browsers as valid end tags, allowing subsequent content to escape sanitization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.
Headplane is a feature-complete Web UI for Headscale. Prior to versions 0.6.3 and 0.7.0-beta.3, Headplane was vulnerable to a path traversal / authorization bypass in the Headscale API client used by node and user rename operations. This issue has been patched in versions 0.6.3 and 0.7.0-beta.3.